Evaluating potential associations between prior maternal yellow fever vaccination and protection against infant adverse outcomes following Zika virus antenatal exposure
International Journal of Epidemiology · 2025
DOI: 10.1093/ije/dyaf147 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Epidemiology, 2025. Verfasst von Everton Falcão de Oliveira und 26 weiteren Autor:innen. Beteiligte Einrichtung: Faculdade de Medicina, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil. Hauptthemen laut MEDLINE: Zika Virus Infection, Microcephaly, Yellow Fever Vaccine, Yellow Fever. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
During the Zika virus (ZIKV) epidemic in Brazil, regional disparities in yellow fever (YF) vaccination coverage and microcephaly incidence led to the hypothesis that maternal YF vaccination could protect against ZIKV infection and microcephaly.
Methods
This case–cohort study was conducted in Campo Grande, Brazil, from 2018 to 2022 and included children with confirmed in utero ZIKV exposure (2015–2018) and a matched control group, totaling 129 mother–child dyads. Maternal blood samples were collected to assess ZIKV exposure and neutralizing YF vaccine-induced antibody (NAb) titers. Associations between YF NAb titer, congenital anomalies, and infant neurodevelopmental delay were evaluated.
Results
Mean YF NAb titers differed between ZIKV-exposed and unexposed mothers (P = .011) and between mothers of children with and without microcephaly (P = .037). Congenital anomalies were associated with lower YF NAb titers (P < .001), prenatal ZIKV exposure (P = .001), and lower family income (P < .001). Neurodevelopmental delay was associated with prenatal ZIKV exposure [adjusted odds ratio (aOR): 4.35, 95% confidence interval (CI): 1.65–13.03], prenatal care with at least six visits (aOR: 0.22, CI: 0.06–0.78), and adequate or large for gestational age birth weight (aOR: 0.09, CI: 0.01–0.44).
Conclusion
Differences in maternal YF NAb titers by ZIKV exposure and microcephaly suggest a potential protective effect of YF vaccination against ZIKV acquisition and/or development of microcephaly, which should be investigated. Developmental delay, although not associated with maternal YF immunity, was associated with antenatal ZIKV exposure, less prenatal care visits, and being small for gestational age.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculdade de Medicina, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil.
- Programa de Pós-Graduação em Doenças Infecciosas e Parasitárias, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil.
- Associação de Pais e Amigos dos Excepcionais, Centro Especializado em Reabilitação, Campo Grande, MS, Brazil.
- Laboratório de Alta Complexidade, Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira, Fiocruz, Rio de Janeiro, RJ, Brazil.
- Laboratório de Imunobiologia das Doenças Infecciosas, Departamento de Imunoniologia, Universidade Federal Fluminense, Niterói, RJ, Brazil.
- Departamento de Desenvolvimento Experimental e Pré-Clínico, Fiocruz, Rio de Janeiro, RJ, Brazil.
ORCID-Profile: Everton Falcão de Oliveira, Zilton Vasconcelos, Karin Nielsen-Saines
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Oliveira, E. F., Santos-Pinto, C. D. B., Venancio, F. A., Quilião, M. E., Gabeira, S. C. O., Carvalho, A. T., Leite, S. H. D. S., Lima, S. M. B., Alves, N. D. S., Moura, L. D. C., Schwarcz, W. D., Azevedo, A. S., Demarchi, L. H. F., Zardin, M. C. S. U., Lichs, G. G. C., Taira, D. L., Souza Fernandes, W., Alves, N. O., Arrua, A. E. C., …, & Nielsen-Saines, K. (2025). Evaluating potential associations between prior maternal yellow fever vaccination and protection against infant adverse outcomes following Zika virus antenatal exposure. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyaf147
Vancouver
Oliveira EF, Santos-Pinto CDB, Venancio FA, Quilião ME, Gabeira SCO, Carvalho AT, et al. Evaluating potential associations between prior maternal yellow fever vaccination and protection against infant adverse outcomes following Zika virus antenatal exposure. International Journal of Epidemiology. 2025. doi:10.1093/ije/dyaf147
BibTeX
@article{Oliveira2025,
author = {Oliveira, Everton Falcão de and Santos-Pinto, Cláudia Du Bocage and Venancio, Fabio Antonio and Quilião, Maria Eulina and Gabeira, Sanny Cerqueira de Oliveira and Carvalho, Amanda Torrentes de and Leite, Silvia Helena Dos Santos and Lima, Sheila Maria Barbosa de and Alves, Nathalia Dos Santos and Moura, Luma da Cruz and Schwarcz, Waleska Dias and Azevedo, Adriana de Souza and Demarchi, Luiz Henrique Ferraz and Zardin, Marina Castilhos Souza Umaki and Lichs, Gislene Garcia de Castro and Taira, Deborah Ledesma and Souza Fernandes, Wagner de and Alves, Natália Oliveira and Arrua, Aline Etelvina Casaril and Nascimento, Ana Isabel do and Mareto, Lisany Krug and Azevedo, Micael Viana de and Maciel, Camila Guadeluppe and Medeiros, Márcio José de and Vasconcelos, Zilton and Cunha, Rivaldo Venâncio da and Nielsen-Saines, Karin},
title = {Evaluating potential associations between prior maternal yellow fever vaccination and protection against infant adverse outcomes following Zika virus antenatal exposure},
journal = {International Journal of Epidemiology},
year = {2025},
doi = {10.1093/ije/dyaf147}
}
EUVIMED